Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study
Annals of Clinical and Translational Neurology · 2024-10 · 11 (10) · 2769-2784
DOI: 10.1002/acn3.52191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 02.09.2024. Verfasst von Fei Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410000, Hunan, P.R. China. Hauptthemen laut MEDLINE: Autoantibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Municipal Natural Science Foundation, Science and Technology Innovation Guidance Project of Hunan Province, Natural Science Foundation of Hunan province, China.
Abstract (Originalsprache)
Objective
This study aimed to investigate the clinical characteristics and predictors of relapse in double negative atypical inflammatory demyelinating disease (IDD) and to explore potential antigenic targets by tissue‐based assays (TBA) using rat brain indirect immunofluorescence.
Methods
We compared the clinical, laboratory, and MRI data of double negative atypical IDD with other IDD patients. Serum samples were collected for TBA. The predictors of relapse were examined over a minimum of 24 months follow‐up.
Results
In our cohort of 98 patients with double negative atypical IDD, there was no significant female predominance (58.2%, 57/98). The lesions primarily affected the spinal cord and brain stem, with fewer cases of involvement in the area postrema (5.1%, 5/98) and longitudinally extensive transverse myelitis (43.9%, 43/98). A total of 62.5% (50/80) patients tested positive for anti‐astrocyte antibodies based on rat brain TBA. Over a median duration of 39.5 months, 80 patients completed the entire follow‐up, and 47.5% (38/80) patients exhibited monophasic course. A total of 36% (18/50) patients positively for anti‐astrocyte antibodies had a monophasic course, which is significantly lower than patients negatively for anti‐astrocyte antibodies (66.7%, 20/30) ( p = 0.008). The presence of anti‐astrocyte antibodies (hazard ratio (HR), 2.243; 95% CI, 1.087–4.627; p = 0.029) and ≥4 cerebrum lesions at first attack (HR, 2.494; 95% CI, 1.224–5.078; p = 0.012) were risk factors for disease relapse, while maintenance immunotherapy during remission (HR, 0.361; 95% CI, 0.150–0.869; p = 0.023) was protective factor.
Interpretation
Double negative atypical IDD are unique demyelinating diseases with a high relapse rate. Maintenance immunotherapy is helpful to the prevention of relapse, particularly in patients with anti‐astrocyte antibodies or ≥4 cerebrum lesions at first attack.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410000, Hunan, P.R. China.
- Clinical Research Center for Neuroimmune and Neuromuscular disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, P.R. China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, P.R. China.
- Department of Acupuncture and Tuina Rehabilitation, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410000, Hunan, P.R. China.
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, 410000, Hunan, P.R. China.
- The "Double-First Class" Application Characteristic Discipline of Hunan Province (Clinical Medicine) Changsha Medical University, Changsha, 410000, Hunan, P.R. China.
ORCID-Profile: Huan Yang
Förderung
- Municipal Natural Science Foundation
- Science and Technology Innovation Guidance Project of Hunan Province
- Natural Science Foundation of Hunan province, China
- Ministry of Education
- Scientific Research Fund of Hunan Provincial Education Department
- National Natural Science Foundation of China
- Changsha Municipal Natural Science Foundation
Zitieren
APA
Jiang, F., Cai, H., Li, H., Yin, W., Ouyang, S., Hu, J., Tu, E., Fu, K., Yin, J., Zhao, Z., Yang, J., Zeng, Q., & Yang, H. (2024). Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study. Annals of Clinical and Translational Neurology, 11(10), 2769-2784. https://doi.org/10.1002/acn3.52191
Vancouver
Jiang F, Cai H, Li H, Yin W, Ouyang S, Hu J, et al. Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study. Annals of Clinical and Translational Neurology. 2024;11(10):2769-2784. doi:10.1002/acn3.52191
BibTeX
@article{Jiang2024,
author = {Jiang, Fei and Cai, Haobing and Li, Hongliang and Yin, Weifan and Ouyang, Song and Hu, Jue and Tu, Ewen and Fu, Ke and Yin, Junjie and Zhao, Zhen and Yang, Jieyu and Zeng, Qiuming and Yang, Huan},
title = {Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
volume = {11},
number = {10},
pages = {2769--2784},
doi = {10.1002/acn3.52191}
}
EUVIMED